Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BigBearai Holdings Inc (BBAI) vs Ginkgo Bioworks Holdings Inc (DNA) Price & Performance

BigBearai Holdings IncTrade
Ginkgo Bioworks Holdings IncTrade

Price performance (Past 24H)

Key statistics

BigBearai Holdings Inc vs Ginkgo Bioworks Holdings Inc — how do they compare? BigBearai Holdings Inc trades at $3.34 (market cap $1.55B), while Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $515.15M). The key difference: BigBearai Holdings Inc is far larger — about 3× Ginkgo Bioworks Holdings Inc's market cap. Which is the better fit depends on your goals.

BBAIDNA
Market Cap
$1.55B$515.15M
Sector
TechnologyHealth
52-Week High
$8.91$16.14
52-Week Low
$2.61$5.48
Enterprise Value
$1.25B$617.10M

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BigBearai Holdings Inc

BBAI trades at $3.27, up 8.64% with a bullish technical signal despite negative profitability metrics. The company reported Q2 2026 revenue growth of 13% and beat EPS estimates, though it remains unprofitable with a -65.2% net income margin. Recent news highlights defense contract execution and generative AI platform expansion for government clients.

The outlook remains challenging due to persistent losses and negative cash flow from operations, though analyst consensus leans neutral with 75% hold ratings. Key risks include execution on government contracts and achieving profitability, while technical indicators suggest near-term bullish momentum.

Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks (DNA) trades at $7.97, down 6.24% today, reflecting ongoing operational challenges. The company reported Q2 2026 revenue of $20 million, a 48% year-over-year decline, as it shifts focus to autonomous lab systems. Despite beating EPS expectations in two of the last three quarters, net losses remain substantial with a -219.6% margin. Technical indicators show bearish momentum with support at $7 and resistance at $9.

DNA faces significant headwinds with declining revenue and persistent losses, though analyst sentiment is mixed with 45% buy ratings. The pivot to new business lines creates uncertainty, while cash burn and competitive pressures present substantial risks. Upside depends on successful execution of the strategic shift and path to profitability.

Returns comparison

Trailing returns across standard periods

About BigBearai Holdings Inc

BigBearai Holdings Inc is a specialized provider of AI-driven decision intelligence solutions, primarily serving the U.S. defense, intelligence, and national security communities. It operationalizes complex data into actionable insights through its core modules—Observe, Orient, and Dominate—to support mission-critical operations and logistics.

Read more on BBAI

About Ginkgo Bioworks Holdings Inc

Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.

Read more on DNA